HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,993 | -11.2% | 41,741 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $48,420 | -23.2% | 41,741 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $63,029 | -39.6% | 41,741 | 0.0% | 0.01% | -45.5% |
Q4 2022 | $104,352 | -40.7% | 41,741 | 0.0% | 0.01% | -38.9% |
Q3 2022 | $176,000 | +51.7% | 41,741 | 0.0% | 0.02% | +50.0% |
Q2 2022 | $116,000 | -75.9% | 41,741 | -50.4% | 0.01% | -70.7% |
Q1 2022 | $481,000 | -36.6% | 84,125 | +1.2% | 0.04% | -32.8% |
Q4 2021 | $759,000 | -13.2% | 83,156 | +1.7% | 0.06% | -21.8% |
Q3 2021 | $874,000 | -30.7% | 81,749 | +0.6% | 0.08% | -32.8% |
Q2 2021 | $1,261,000 | -3.5% | 81,249 | +0.8% | 0.12% | -9.4% |
Q1 2021 | $1,307,000 | +6.5% | 80,619 | +39.1% | 0.13% | -1.5% |
Q4 2020 | $1,227,000 | +41.8% | 57,957 | -0.7% | 0.13% | +21.5% |
Q3 2020 | $865,000 | -11.8% | 58,367 | -12.5% | 0.11% | -10.8% |
Q2 2020 | $981,000 | +23.1% | 66,683 | -1.8% | 0.12% | +18.8% |
Q1 2020 | $797,000 | -54.6% | 67,921 | -9.1% | 0.10% | -34.8% |
Q4 2019 | $1,755,000 | – | 74,680 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |